Immunomorphologic profile and Epstein–Barr virus status of a cohort of 35 cases of extranodal natural killer/T-cell lymphoma, nasal type of upper aerodigestive tract from a tertiary care center in South India

References

• Swerdlow SH, Campo E, Harris NL, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.
   Google Scholar
• Gualco G, Domeny-Duarte P, Chioato L, et al.Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis. Am J Surg Pathol 2011;35:1195–1203.
   PubMed Web of Science ®Google Scholar
• Arber DA, Weiss LM, Albújar PF, et al. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 1993;17:392–399.
   Google Scholar
• Quintanilla-Martínez L, Lome-Maldonado C, Ott G, et al. Primary intestinal non-Hodgkin's lymphoma and Epstein-Barr virus: high frequency of EBV-infection in T-cell lymphomas of Mexican origin. Leuk Lymphoma 1998;30:111–121.
   PubMed Web of Science ®Google Scholar
• Weiss LM, Arber DA, Strickler JG. Nasal T-cell lymphoma. Ann Oncol 1994;5(Suppl. 1):39–42.
   PubMedGoogle Scholar
• Macon WR. Peripheral T-cell lymphomas. Hematol Oncol Clin North Am 2009;23:829–842.
   PubMed Web of Science ®Google Scholar
• Reddy RR, Singh G, Prathima KJ, et al. CD-3 positive extranodal T-cell lymphoma of nasal type with skin involvement. Indian J Dermatol Venereol Leprol 2006;72:215–217.
   PubMedGoogle Scholar
• Sharma A, Dandekar M, Deshmukh S, et al. Nasal extranodal natural killer T cell lymphoma: an atypical presentation. J Laryngol Otol 2011;125:1181–1184.
   PubMed Web of Science ®Google Scholar
• Mohapatra A, Viswabandya A, Samuel R, et al. NK/T-cell lymphoma in a renal transplant recipient and review of literature. Indian J Nephrol 2011;21:44–47.
   PubMedGoogle Scholar
• Patel V, Mahajan S, Kharkar V, et al. Nasal extranodal NK/T-cell lymphoma presenting as a perforating palatal ulcer: a diagnostic challenge. Indian J Dermatol Venereol Leprol 2006;72:218–221.
   PubMedGoogle Scholar
• Metgud RS, Doshi JJ, Gaurkhede S, et al. Extranodal NK/T-cell lymphoma, nasal type (angiocentric T-cell lymphoma): a review about the terminology. J Oral Maxillofac Pathol 2011;15:96–100.
   PubMedGoogle Scholar
• Valiathan M, Rao RV, Rao L, et al. Nasal NK/T cell lymphoma mimicking a squamous cell carcinoma: a case report. Indian J Pathol Microbiol 2005;48:257–259.
   PubMedGoogle Scholar
• D’Souza GA, Sunad R, Rajagopalan N, et al. NK/T-cell lymphoma in AIDS. J Assoc Physicians India 2006;54:890–892.
   PubMedGoogle Scholar
• Mehta V, Balachandran C, Bhat S, et al. Nasal NK/T cell lymphoma presenting as a lethal midline granuloma. Indian J Dermatol Venereol Leprol 2008;74:145–147.
   PubMed Web of Science ®Google Scholar
• Chan JK. Natural killer cell neoplasms. Anat Pathol 1998;3:77–145.
   PubMedGoogle Scholar
• Chan J, Tsang W, Ng C. Clarification of CD3 immunoreactivity in nasal T/natural killer cell lymphomas: the neoplastic cells are often CD3 epsilon+. Blood 1996;87:839–841.
   PubMed Web of Science ®Google Scholar
• Jaffe ES. Nasal and nasal-type T/NK cell lymphoma: a unique form of lymphoma associated with the Epstein-Barr virus. Histopathology 1995;27:581–583.
   PubMed Web of Science ®Google Scholar
• Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103–111.
   PubMed Web of Science ®Google Scholar
• Tsang WY, Chan JK, Ng CS, et al. Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas. Am J Surg Pathol 1996;20:202–210.
   PubMed Web of Science ®Google Scholar
• Hasserjian RP, Harris NL. NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype. Am J Clin Pathol 2007;127:860–868.
   PubMed Web of Science ®Google Scholar
• Gulley ML, Tang W. Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn 2008;10:279–292.
   PubMed Web of Science ®Google Scholar
• Gulley ML. Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn 2001;3:1–10.
   PubMed Web of Science ®Google Scholar
• Au W-Y, Ma S-Y, Chim C-S, et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol 2005;16: 206–214.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Koshikawa T, Koike K, et al. Phenotypic analysis of peripheral T cell lymphoma among the Japanese. Acta Pathol Jpn 1993;43:396–412.
   PubMedGoogle Scholar
• Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006;24:612–618.
   PubMed Web of Science ®Google Scholar
• Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008;26:4124–4130.
   PubMed Web of Science ®Google Scholar
• Feng Y-F, Wu Q-L, Zong Y-S. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection. Ai Zheng 2007;26:1170–1176.
   PubMedGoogle Scholar
• Chan JK, Yip TT, Tsang WY, et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 1994;18:938–946.
   PubMed Web of Science ®Google Scholar
• Peh SC, Sandvej K, Pallesen G. Epstein-Barr virus (EBV) in Malaysian upper-aerodigestive-tract lymphoma: incidence and sub-type. Int J Cancer 1995;61:327–332.
   PubMed Web of Science ®Google Scholar
• Ko YH, Cho E-Y, Kim J-E, et al. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status. Histopathology 2004;44:480–489.
   PubMed Web of Science ®Google Scholar
• Ichimura K, Kagami Y, Suzuki R, et al. Phenotypic analysis of peripheral T/NK cell lymphoma: study of 408 Japanese cases with special reference to their anatomical sites. Pathol Int 2003;53:333–344.
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee SS, Park JH, et al. Prevalence of EBV RNA in sinonasal and Waldeyer's ring lymphomas. J Korean Med Sci 1994;9:281–288.
   PubMedGoogle Scholar
• Zhang B, Zong Y, He J, et al. Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection. Chin Med J 2003;116:913–917.
   PubMed Web of Science ®Google Scholar
• Zhong B, Zhang X, Li M, et al. [Study of the pathology, immunophenotype, etiology and genetic marker of NK/T-cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi 2003;24:505–509.
   PubMedGoogle Scholar
• Kimura H, Ito Y, Kawabe S, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 2012;119:673–686.
   PubMed Web of Science ®Google Scholar
• Li Y-X, Wang H, Feng X-L, et al. Immunophenotypic characteristics and clinical relevance of CD56 + and CD56- extranodal nasal-type natural killer/T-cell lymphoma. Leuk Lymphoma 2011;52:417–424.
   PubMed Web of Science ®Google Scholar
• Yao B, Li Y-X, Fang H, et al. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases]. Ai Zheng 2006;25:465–470.
   PubMedGoogle Scholar
• Assanasen T, Wannakrairot P, Keelawat S, et al. Extranodal malignant lymphoma of the upperaerodigestive tract in King Chulalongkorn Memorial Hospital according to WHO classification. J Med Assoc Thai 2004;87(Suppl. 2):S249–S254.
   PubMedGoogle Scholar
• Ng SB, Lai KW, Murugaya S, et al. Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol 2004;17:1097–1107.
   PubMed Web of Science ®Google Scholar
• Naresh KN, Agarwal B, Nathwani BN, et al. Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: a review of 200 consecutive cases by a panel of five expert hematopathologists. Leuk Lymphoma 2004;45:1569–1577.
   PubMed Web of Science ®Google Scholar
• Sahni CS, Desai SB. Distribution and clinicopathologic characteristics of non-Hodgkin's lymphoma in India: a study of 935 cases using WHO classification of lymphoid neoplasms (2000). Leuk Lymphoma 2007;48:122–133.
   PubMed Web of Science ®Google Scholar
• Gaal K, Sun NC, Hernandez AM, et al. Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol 2000;24:1511–1517.
   PubMed Web of Science ®Google Scholar
• Van Gorp J, De Bruin PC, Sie-Go DM, et al. Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases. Histopathology 1995;27:139–148.
   PubMed Web of Science ®Google Scholar
• Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501–4513.
   PubMed Web of Science ®Google Scholar
• Ko YH, Ree HJ, Kim WS, et al. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans. Cancer 2000;89:2106–2116.
   PubMed Web of Science ®Google Scholar
• Wong KF, Chan JK, Cheung MM, et al. Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon. Am J Clin Pathol 2001;115:266–270.
   PubMed Web of Science ®Google Scholar
• Sung CO, Ko YH. Bone marrow is involved in less than 10% of patients with nasal-type NK/T cell lymphoma at initial diagnosis. J Korean Med Sci 2004;19:229–233.
   PubMed Web of Science ®Google Scholar
• Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998;16:70–77.
   PubMed Web of Science ®Google Scholar
• Kwong YL, Chan AC, Liang R, et al. CD56 + NK lymphomas: clinicopathological features and prognosis. Br J Haematol 1997;97: 821–829.
   PubMed Web of Science ®Google Scholar
• García-Cosío M, Santón A, Méndez MC, et al. Nasopharyngeal/nasal type T/NK lymphomas: analysis of 14 cases and review of the literature. Tumori 2003;89:278–284.
   PubMed Web of Science ®Google Scholar
• Schwartz EJ, Molina-Kirsch H, Zhao S, et al. Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases. Am J Clin Pathol 2008;130:343–351.
   PubMed Web of Science ®Google Scholar
• Elenitoba-Johnson KS, Zarate-Osorno A, Meneses A, et al. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol 1998;11:754–761.
   PubMed Web of Science ®Google Scholar
• Li L, Liu Y, Zhuang H, et al. [Extranodal nasal type NK/T-cell lymphoma: clinicopathologic and prognostic study of 55 cases].Zhonghua Bing Li Xue Za Zhi 2009;38:237–242.
   PubMedGoogle Scholar
• Yasuda H, Sugimoto K, Imai H, et al. Expression levels of apoptosis-related proteins and Ki-67 in nasal NK / T-cell lymphoma. Eur J Haematol 2009;82:39–45.
   PubMed Web of Science ®Google Scholar
• Kanavaros P, Lescs MC, Brière J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993;81:2688–2695.
   PubMed Web of Science ®Google Scholar
• Venkitaraman AR, Seigneurin JM, Lenoir GM, et al. Infections due to the human herpesviruses in southern India: a seroepidemiological survey. Int J Epidemiol 1986;15:561–566.
   PubMed Web of Science ®Google Scholar
• Chang CM, Yu KJ, Mbulaiteye SM, et al. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res 2009;143:209–221.
   PubMed Web of Science ®Google Scholar
• Emmanuel B, Kawira E, Ogwang MD, et al. African Burkitt lymphoma: age-specific risk and correlations with malaria biomarkers. Am J Trop Med Hyg 2011;84:397–401.
   PubMed Web of Science ®Google Scholar
• Karnik S, Srinivasan B, Nair S. Hodgkin's lymphoma: immunohistochemical features and its association with EBV LMP-1. Experience from a South Indian hospital. Pathology 2003;35:207–211.
   Google Scholar
• Dinand V, Dawar R, Arya LS, et al. Hodgkin's lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin's and Reed-Sternberg cells. Eur J Cancer 2007;43:161–168.
   PubMed Web of Science ®Google Scholar
• Harris NL. The many faces of Hodgkin's disease around the world: what have we learned from its pathology?Ann Oncol 1998; 9(Suppl. 5):S45–S56.
   PubMedGoogle Scholar
• Yamaguchi M, Suzuki R, Kwong Y-L, et al. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 2008;99:1016–1020.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Kwong Y-L, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 2011;29:4410–4416.
   PubMed Web of Science ®Google Scholar